Septerna (SEPN) Tax Provisions (2024 - 2026)

Name: Septerna (SEPN) Tax Provisions (2024 - 2026) | Business Quant
Creator: Business Quant

Septerna's quarterly Tax Provisions came in at $337000.0 in Q1 2026, up 2708.33% quarter-over-quarter from $12000.0 in Q4 2025.

Septerna has reported Tax Provisions for 3 years, with the latest figure at $337000.0 in Q1 2026.

For the quarter ending Q1 2026, Tax Provisions changed N/A year-over-year to $337000.0; the trailing twelve-month figure through Mar 2026 stood at $349000.0 (up 286.63% YoY), and the FY2025 full-year result was $12000.0, up 102.41% from the prior year.
Tax Provisions for Q1 2026 stood at $337000.0, up from $12000.0 in the prior quarter.
The five-year high for Tax Provisions was $337000.0 in Q1 2026, with the low at -$160000.0 in Q4 2024.
Average Tax Provisions over 3 years is $42500.0, with a median of $52500.0 recorded in 2024.
Peak annual rise in Tax Provisions reached 107.5% in 2025, while the deepest fall reached 107.5% in 2025.
Tracing SEPN's Tax Provisions over 3 years: stood at -$160000.0 in 2024, then jumped by 107.5% to $12000.0 in 2025, then jumped by 2708.33% to $337000.0 in 2026.
The last three Tax Provisions figures came in at $337000.0 (Q1 2026), $12000.0 (Q4 2025), and -$160000.0 (Q4 2024), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-11.20 Mn
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-859,000.00
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	221.50 Mn
7	Evaxion A	62.56 Bn	62.54 Bn	-	216,000.00
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	104.00 Mn
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	15.66 Mn
10	Septerna	1.34 Bn	1.34 Bn	-	337,000.00

Download Data 🔒